{"id":468,"date":"2019-01-07T04:36:27","date_gmt":"2019-01-07T04:36:27","guid":{"rendered":"http:\/\/www.cscr.in\/symposium\/?page_id=468"},"modified":"2019-01-07T05:06:38","modified_gmt":"2019-01-07T05:06:38","slug":"cgts-2018","status":"publish","type":"page","link":"https:\/\/www.cscr.res.in\/symposium\/index.php\/cgts-2018\/","title":{"rendered":"CGTS 2018"},"content":{"rendered":"

3rd<\/sup> Annual Cell and Gene Therapy Symposium<\/strong><\/span><\/p>\n

6-7 September, 2018<\/strong><\/span><\/p>\n

Scientific Program<\/h3>\n

DAY-1: THURSDAY, 06TH<\/sup> SEPTEMBER, 2018<\/strong><\/h4>\n

9:30 to 10:00AM: REGISTRATION<\/strong>\u00a0<\/strong><\/h4>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
10:00 to 10:15AM<\/p>\n

 <\/p>\n

10:15 to 10:20AM<\/p>\n

 <\/p>\n

10:20 to 10:25AM<\/p>\n

\u00a0<\/strong><\/td>\n

Welcome and introductory remarks \u2013 Director \/ Principal, CMC, Vellore<\/strong><\/p>\n

 <\/p>\n

Address by Dr. Renu Swarup<\/strong>, Secretary, Department of Biotechnology (DBT), Govt. of India<\/p>\n

 <\/p>\n

Address by Dr. Balram Bhargava<\/strong>, Secretary, Department of Health Research (DHR), Govt. of India & Director General, Indian Council of Medical Research (ICMR)<\/td>\n<\/tr>\n

\n
Session-1: <\/em><\/strong>\u00a0IMMUNE CELL THERAPY<\/strong><\/h5>\n<\/td>\n<\/tr>\n
10:25 to 10:30AM<\/td>\nIntroduction to the session<\/td>\n<\/tr>\n
10:30 to 11:00AM<\/td>\nStrategies to Drive CAR-T Cells into Solid Tumors<\/td>\nAvery Posey<\/strong><\/p>\n

Parker Institute for Cancer Immunotherapy,<\/p>\n

University of Pennsylvania, USA<\/td>\n<\/tr>\n

11:00 to 11:30AM<\/td>\nCAR T-cells against lymphoid cells: Hurdles in transitioning from B cell to T cell malignancies<\/td>\nTrent Spencer<\/strong><\/p>\n

Emory University<\/p>\n

School of Medicine, USA<\/td>\n<\/tr>\n

11:30 to 12:00PM<\/td>\nIndigenous CAR T cell technology development: Present and future in India<\/td>\nRahul Purwar<\/strong><\/p>\n

Indian Institute of Technology Bombay, India<\/td>\n<\/tr>\n

12:00 to 1:00PM<\/td>\nLunch<\/em><\/strong><\/td>\n<\/tr>\n
\n
Session-2: <\/em><\/strong>\u00a0CELL AND GENE THERAPY IN NEUROLOGICAL DISORDERS<\/strong><\/h5>\n<\/td>\n<\/tr>\n
1:00 to 1:05PM<\/td>\nIntroduction to the session<\/td>\n<\/tr>\n
1:05 to 1:35PM<\/td>\nNext-generation gene therapy products for Duchenne muscular dystrophy and other muscle disorders<\/td>\nMarinee Chuah<\/strong><\/p>\n

Free University of Brussels & University of Leuven, Belgium<\/td>\n<\/tr>\n

1:35 to 2:05PM<\/td>\nStem cell therapy for stroke recovery: Hope or hype?<\/td>\nPadma Srivastava<\/strong><\/p>\n

All India Institute of Medical Sciences, New Delhi, India<\/td>\n<\/tr>\n

2:05 to 2:35PM<\/td>\nGene therapy for Duchenne muscular dystrophy (DMD) \u2013 The India Scenario<\/td>\nArun Shastry<\/strong><\/p>\n

Dystrophy Annihilation Research Trust, India<\/td>\n<\/tr>\n

2:35 to 3:05PM<\/td>\nPacking in portions: Dual vector strategies to expand AAV vector capacity<\/td>\nArkasubhra Ghosh<\/strong><\/p>\n

Narayana Nethralaya Foundation, India<\/td>\n<\/tr>\n


\n<\/strong><\/p>\n
Session-3: <\/em><\/strong>NON-VIRAL GENE TRANSFER TECHNOLOGY<\/strong><\/h5>\n<\/td>\n<\/tr>\n
3:05 to 3:10PM<\/td>\nIntroduction to the session<\/td>\n<\/tr>\n
 <\/p>\n

3:10 to 3:40PM<\/td>\n

Design and delivery of messenger RNA based-therapeutics<\/td>\nChantal Pichon<\/strong><\/p>\n

Center for Molecular Biophysics-CNRS, University of Orl\u00e9ans, France<\/td>\n<\/tr>\n

3:40to 4:10PM<\/td>\nsiRNA for therapeutic gene regulation<\/td>\nNarendra Chirmule<\/strong><\/p>\n

Biocon Research Limited, India<\/td>\n<\/tr>\n

4:10 to 4:40PM<\/td>\nNovel strategies for cationic lipid enabled CRISPR\/Cas9 based genome editing in hematopoietic cells<\/td>\nSrujan Marepally<\/strong><\/p>\n

Centre for Stem Cell Research, India<\/td>\n<\/tr>\n

4:40 to 5:05PM<\/td>\nTea Break \/ CSCR Posters<\/em><\/strong><\/td>\n<\/tr>\n
\n
Session-4:<\/em><\/strong> TECHNOLOGY ADVANCES<\/strong><\/h5>\n<\/td>\n<\/tr>\n
5:05 to 5:10PM<\/td>\nIntroduction to the session<\/td>\n\u00a0<\/strong><\/td>\n<\/tr>\n
5:10 to 5:40PM<\/td>\nNew and improved AAV vectors<\/td>\nArun Srivastava<\/strong><\/p>\n

University of Florida<\/p>\n

College of Medicine, USA<\/td>\n<\/tr>\n

5:40 to 6:10PM<\/td>\nEnabling the CAR-T revolution:\u00a0 Clinically compliant systems for the processing and release of CAR-T products<\/td>\nRoland Leathers<\/strong><\/p>\n

Thermo Fisher Scientific, Switzerland<\/td>\n<\/tr>\n

6:10 to 6:40PM<\/td>\nAutomated manufacturing of cell therapy products with CliniMACS Prodigy system \u2013 CAR T cells and more<\/td>\nRyan Wu Feiyi<\/strong><\/p>\n

Miltenyi Biotec Asia Pacific, Singapore<\/td>\n<\/tr>\n

\n
KEY NOTE ADDRESS<\/strong><\/h5>\n<\/td>\n<\/tr>\n
6:40 to 6:45PM<\/td>\nIntroduction<\/td>\n<\/tr>\n
6:45 to 7:45PM<\/td>\nGene therapy – From promise to reality<\/td>\nTrent Spencer<\/strong><\/p>\n

Emory University<\/p>\n

School of Medicine, USA<\/td>\n<\/tr>\n

7:45PM onwards<\/td>\nDinner<\/em><\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

DAY-2: FRIDAY, 07TH<\/sup> SEPTEMBER, 2018<\/strong><\/h4>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n
Session-5:<\/em><\/strong> GENE THERAPY<\/strong><\/h5>\n<\/td>\n<\/tr>\n
8:30 to 8:35AM<\/td>\nIntroduction to the session<\/td>\n<\/tr>\n
8:35 to 9:05AM<\/td>\nGene replacement vs gene editing for gene therapy of hemophilia: Promises and challenges<\/td>\nThierry VandenDriessche<\/strong><\/p>\n

Free University of Brussels & University of Leuven, Belgium<\/td>\n<\/tr>\n

9:05 to 9:35AM<\/td>\nAssessing genotoxicity and efficacy of zinc finger nuclease modification of primary human and canine cells for FVIII secretion<\/td>\nJaichandran Sivalingam<\/strong><\/p>\n

National Cancer Centre & Agency for Science, Technology and Research, Singapore<\/td>\n<\/tr>\n

9:35 to 10:05AM<\/td>\nGene therapy for hemophilia<\/td>\nAlok Srivastava<\/strong><\/p>\n

Centre for Stem Cell Research & Christian Medical College, Vellore, India<\/td>\n<\/tr>\n

10:05 to 10:35AM<\/td>\nGene therapy of liver cancer with AAV3 vectors<\/td>\nArun Srivastava<\/strong><\/p>\n

University of Florida<\/p>\n

College of Medicine, USA<\/td>\n<\/tr>\n

10:35 to 11:00AM<\/td>\nTea Break \/ CSCR Posters<\/em><\/strong><\/td>\n<\/tr>\n
 <\/p>\n

 <\/p>\n

Session-6:<\/em><\/strong> GENE EDITING<\/strong><\/h5>\n<\/td>\n<\/tr>\n
11:00 to 11:05AM<\/td>\nIntroduction to the session<\/td>\n<\/tr>\n
11:05 to 11:35AM<\/td>\nGene editing approaches for treatment of beta-hemoglobinopathies<\/td>\nSaravanabhavan Thangavel<\/strong><\/p>\n

Centre for Stem Cell Research, India<\/td>\n<\/tr>\n

11:35 to 12:05PM<\/td>\nTherapeutic genome editing for beta-hemoglobinopathies<\/td>\nMohankumar Murugesan<\/strong><\/p>\n

Centre for Stem Cell Research, India<\/td>\n<\/tr>\n

12:05 to 12:30PM<\/td>\nA proposed framework for governing human gene editing in India<\/td>\nShambhavi Naik<\/strong><\/p>\n

Takshashila Institution, India<\/td>\n<\/tr>\n

12:30 to 1:30PM<\/td>\nLunch<\/em><\/strong><\/td>\n<\/tr>\n
\n
Session-7:<\/em><\/strong> APPLICATIONS OF iPSC TECHNOLOGY<\/strong><\/h5>\n<\/td>\n<\/tr>\n
1:30 to 1:35PM<\/td>\nIntroduction to the session<\/td>\n<\/tr>\n
1:35 to 2:05PM<\/td>\nTranslational applications of pluripotent stem cells<\/td>\nShaji Velayudhan<\/strong><\/p>\n

Centre for Stem Cell Research & Christian Medical College, Vellore, India<\/td>\n<\/tr>\n

2:05 to 2:35PM<\/td>\niPSCs for ocular regeneration: Progress so far, challenges and way forward<\/td>\nIndumathi Mariappan<\/strong><\/p>\n

L V Prasad Eye Institute, India<\/td>\n<\/tr>\n

2:35 to 3:05PM<\/td>\nDeveloping pluripotent stem cells for clinical applications<\/td>\nGlyn Stacey<\/strong><\/p>\n

International Stem Cell Banking Initiative & SSC Bio Ltd., UK<\/td>\n<\/tr>\n

3:05 to 3:15PM<\/td>\nConclusion remarks<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Gallery<\/h3>\n

[soliloquy id=”431″]<\/p \n\n","protected":false},"excerpt":{"rendered":"

3rd Annual Cell and Gene Therapy Symposium 6-7 September, 2018 Scientific Program DAY-1: THURSDAY, 06TH SEPTEMBER, 2018 9:30 to 10:00AM: REGISTRATION\u00a0 10:00 to 10:15AM   10:15 to 10:20AM   10:20 to 10:25AM \u00a0 Welcome and introductory remarks \u2013 Director \/ Principal, CMC, Vellore   Address by Dr. Renu Swarup, Secretary, Department of Biotechnology (DBT), Govt. […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/pages\/468"}],"collection":[{"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/comments?post=468"}],"version-history":[{"count":8,"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/pages\/468\/revisions"}],"predecessor-version":[{"id":479,"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/pages\/468\/revisions\/479"}],"wp:attachment":[{"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/media?parent=468"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}